EPAX® Cetoleic 10 contains both cetoleic acid – an Omega-11 marine lipid – and gondoic acid (Omega-9). Rich in long-chain monounsaturated fatty acids (LC-MUFAs), new Epax research indicates that it may have particular benefits for skin health.
In a double-blind, placebo-controlled, randomized pilot trial, skin redness was significantly reduced in subjects taking EPAX® Cetoleic 101. And although it contains less EPA and DHA than typical Omega-3 products, another study has found that it can boost the Omega-3 index2.
Previous studies on animals have also indicated that fish oils rich in cetoleic acid can reduce inflammation and atherosclerosis, and help prevent the development of metabolic syndrome3,4.
All EPAX® oils are produced to the highest quality standards, in a facility approved by US FDA for manufacture of Pharmaceutical Intermediates and approved by the Norwegian Medicines Agency for manufacture of Active Pharmaceutical Ingredients (API).
1. Mildenberger J. and Midtbø LK. Optihud: A nutritional, single centre, placebo controlled, randomised, blinded study of the effect of mackerel oil on skin quality and omega-3 index. Internal report 2022.
2. Midtbø LK and Mildenberger J. CetoIndex. A nutritional, single centre, placebo controlled, randomised, blinded study of the effect of different fish oils on omega-3 index. Internal report 2022.
3. Yang ZH, Emma-Okon B, Remaley AT. Dietary marine-derived long-chain monounsaturated fatty acids and cardiovascular disease risk: a mini review. Lipids Health Dis. Nov 22 2016;15(1):201.
4. Yang ZH, Miyahara H, Mori T, Doisaki N, Hatanaka A. Beneficial effects of dietary fish-oil-derived monounsaturated fatty acids on metabolic syndrome risk factors and insulin resistance in mice. J Agric Food Chem. Jul 13 2011;59(13):7482-9.